Compare AIHS & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIHS | ACON |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.4M |
| IPO Year | 2018 | 2022 |
| Metric | AIHS | ACON |
|---|---|---|
| Price | $1.30 | $6.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 46.7K | 33.1K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,560,626.00 | $67,483.00 |
| Revenue This Year | N/A | $145.39 |
| Revenue Next Year | N/A | $145.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $0.83 | $5.55 |
| 52 Week High | $17.00 | $3,499.49 |
| Indicator | AIHS | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 45.78 | 41.55 |
| Support Level | $1.28 | $6.34 |
| Resistance Level | $1.43 | $8.09 |
| Average True Range (ATR) | 0.13 | 0.46 |
| MACD | 0.05 | 0.09 |
| Stochastic Oscillator | 70.21 | 23.23 |
Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.